FindTrial
Sign In

Effect Of Triphala Kwath Parisheka(Stye).

A randomized controlled clinical trial to study the effect of thriphala kwath parisheka in anjannamika with special reference to stye. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072323
Enrollment
68
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H000- Hordeolum (externum) (internum) ofeyelid

Interventions

None listed

Sponsors

Dr Shivani Virkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having sign and symptoms of Anjannamika . Age group 15-60 years. Selection of patient will be irrespective of Gender socioeconomic status and religion.

Exclusion criteria

Exclusion criteria: Patients age below 15 years and above 60 years. Patients who will not give written consent. Patient having diseases like DM, HIV+ve, HbsAg, etc.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of Anjannamika (stye) after application of triphala kwath parishekaTimepoint: 7 days—

Secondary

MeasureTime frame
where the trial group (triphala kwath parisheka) stands in comparison with control group (haridradi parisheka) in reduction with the signs & symptoms of Anjannamika(stye).Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Shivani Namdev Virkar

SMBT Ayurved College and Hospital

dr.tusharfirke@gmail.com9823388720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026